Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer-Reference-Cited by-同舟云学术

Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer

Published:2015-02-19 Issue:1 Volume:10 Page:
ISSN:1748-717X
Container-title:Radiation Oncology
language:en
Short-container-title:Radiat Oncol

Author:

Gurka Marie K,Chen Leonard N,Bhagat Aditi,Moures Rudy,Kim Joy S,Yung Thomas,Lei Siyuan,Collins Brian T,Krishnan Pranay,Suy Simeng,Dritschilo Anatoly,Lynch John H,Collins Sean P

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13014-015-0351-6.pdf

Reference42 articles.

1. Marks LB, Carroll PR, Dugan TC, Anscher MS. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys. 1995;31:1257–80.

2. Mathieu R, Arango JD, Beckendorf V, Delobel JB, Messai T, Chira C, et al. Nomograms to predict late urinary toxicity after prostate cancer radiotherapy. World J Urol. 2014;32:743–51.

3. Eifel PJ, Levenback C, Wharton JT, Oswald MJ. Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 1995;32:1289–300.

4. Lawton CA, Won M, Pilepich MV, Asbell SO, Shipley WU, Hanks GE, et al. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys. 1991;21:935–9.

5. Margulis V, Sagalowsky AI. Assessment of hematuria. Med Clin North Am. 2011;95:153–9.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genitourinary toxicity in patients receiving TURP prior to hypofractionated radiotherapy for clinically localized prostate cancer: A scoping review;Urologic Oncology: Seminars and Original Investigations;2024-06

2. Late Urinary Toxicity After Extreme or Moderate Hypofractionated Prostate Radiation Therapy in Patients With Prior Transurethral Resection of Prostate;International Journal of Radiation Oncology*Biology*Physics;2024-06

3. Extreme hypofractionated stereotactic radiotherapy for localized prostate Cancer: Efficacy and late urinary toxicity according to transurethral resection of the prostate history;Clinical and Translational Radiation Oncology;2024-05

4. Stereotactic body radiation therapy for prostate cancer after surgical treatment of prostatic obstruction: Impact on urinary morbidity and mitigation strategies;Clinical and Translational Radiation Oncology;2024-03

5. Predicting the germline dependence of hematuria risk in prostate cancer radiotherapy patients;Radiotherapy and Oncology;2023-08